In summary, our results demonstrated that BAMBIhigh DLBCL cells may tend to suppress the anti‐tumour activity of CD4 effector, regulatory, and Th1 subsets by enhancing TGFB1‐TGFBR2 signalling in the TME. This evidence concerns the gene TGFBR2 and diffuse large B-cell lymphoma.